FDA Approvals: Allegra Oral Solution, Noxafil, Mirapex
The FDA has approved fexofenadine (Allegra), a new indication for posaconazole (Noxafil), and a new indication for pramipexole (Mirapex). (CME,CE)Medscape Medical News (Source: Medscape Pulmonary Medicine Headlines)
Once-Daily MIRAPEX ER Now Approved by FDA for Both Early and Advanced Parkinson's Disease
New treatment option for the nearly one million Americans affected by Parkinson's disease
RIDGEFIELD, Conn., March 23 (HSMN NewsFeed) -- Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has a... Biopharmaceuticals, FDA, NeurologyBoehringer Ingelheim Pharmaceuticals, Mirapex ER, Parkinson's disease (Source: HSMN NewsFeed)
